UroGen Pharma (URGN) Amortizatization of Intangibles (2019 - 2025)
UroGen Pharma's Amortizatization of Intangibles history spans 7 years, with the latest figure at -$1.3 million for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles rose 53.71% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $476000.0, up 136.48%, while the annual FY2025 figure was $476000.0, 136.48% up from the prior year.
- Amortizatization of Intangibles reached -$1.3 million in Q4 2025 per URGN's latest filing, down from $859000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.4 million in Q2 2024 to a low of -$2.9 million in Q4 2024.
- Average Amortizatization of Intangibles over 5 years is $54900.0, with a median of $272500.0 recorded in 2021.
- Peak YoY movement for Amortizatization of Intangibles: skyrocketed 808.0% in 2023, then crashed 5496.23% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$704000.0 in 2021, then surged by 73.86% to -$184000.0 in 2022, then soared by 128.8% to $53000.0 in 2023, then plummeted by 5496.23% to -$2.9 million in 2024, then surged by 53.71% to -$1.3 million in 2025.
- Per Business Quant, the three most recent readings for URGN's Amortizatization of Intangibles are -$1.3 million (Q4 2025), $859000.0 (Q3 2025), and $167000.0 (Q2 2025).